Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains a significant challenge in healthcare, with conventional chemotherapy often associated with systemic toxicity and limited efficacy due to poor selectivity for cancer cells. To address these limitations, this thesis presents the development of novel drug delivery systems for targeted cancer therapy. The study aims to explore the design and optimization of drug delivery systems that can enhance the specificity of anticancer agents to tumor cells while minimizing adverse effects on healthy tissues. Chapter One provides a comprehensive introduction to the research topic, highlighting the background of the study, problem statement, objectives, limitations, scope, significance, and structure of the thesis. This chapter also defines key terms essential for understanding the subsequent chapters. Chapter Two consists of a detailed literature review that examines existing drug delivery systems for cancer therapy, including liposomes, nanoparticles, micelles, and polymer-based carriers. The review critically analyzes the advantages and limitations of each system, highlighting the importance of targeting strategies in improving therapeutic outcomes. Chapter Three outlines the research methodology employed in this study, including the selection of materials, formulation techniques, characterization methods, and in vitro/in vivo evaluation of the developed drug delivery systems. The chapter also discusses the ethical considerations and statistical analyses used to interpret the results. In Chapter Four, the findings of the research are elaborately discussed, focusing on the efficacy and safety profiles of the novel drug delivery systems in delivering anticancer drugs to tumor cells. The chapter presents data on drug release kinetics, cellular uptake, cytotoxicity, and pharmacokinetic properties, providing insights into the mechanisms of action and potential clinical applications. Chapter Five serves as the conclusion and summary of the thesis, highlighting the key findings, implications, and future directions for research in the field of targeted cancer therapy. The chapter emphasizes the significance of developing personalized and precision medicine approaches to improve cancer treatment outcomes while minimizing side effects. In conclusion, the "Development of Novel Drug Delivery Systems for Targeted Cancer Therapy" thesis represents a significant contribution to the field of oncology by proposing innovative strategies to enhance the efficacy and selectivity of anticancer treatments. The findings of this study have the potential to advance the development of personalized therapies that can improve patient outcomes and quality of life in cancer patients.